Abstract
Cytomegalovirus (CMV) disease is a serious infectious complication in compromised hosts. Therefore, there are several studies on the diagnosis and prophylactic/pre-emptive therapy of CMV diseases in patients with solid organ transplants, bone marrow transplants, hematopoietic stem cell transplants, and HIV diseases. However, in patients with autoimmune disease, there are only few studies on the diagnosis and prediction of CMV diseases. In the present article, we described three autoimmune cases that developed CMV gastrointestinal disease because of therapy-related immunosuppression. Although all three patients had a low-level CMV antigenemia without diarrhea or melena, CMV was detected in the gastrointestinal tract tissue. We concluded that CMV-antigenemia assay has a limited value in the diagnosis and prediction of CMV gastrointestinal disease in patients with autoimmune diseases, and that immunohistochemical confirmation of CMV tissue involvement should be recommended especially when the typical clinical gastrointestinal manifestations are lacking.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sultan SM, Ioannou Y, Isenberg DA (1999) A review of gastrointestinal manifestations of systemic lupus erythematosus. Rheumatology 38:917–932
Takeno M, Ishigatsubo Y (2006) Intestinal manifestations in systemic lupus erythmatosus. Intern Med 45:41–42
Goodgame CW (1993) Gastrointestinal cytomegalovirus disease. Ann Intern Med. 119:924–935
Sekigawa I, Nawata M, Seta N et al (2002) Cytomegalovirus infection in patients with systemic lupus erythematosus. Clin Exp Rheumatol 20:559–564
Manteiga R, Martino R, Suruda A et al (1998) Cytomegalovirus p65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem cell transplantation: a single-center experience. Bone Marrow Transplant 22:899–904
Senechal M, Dorent R, Montcel ST et al (2003) Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia. Clin Transplant 17:423–427
Mori T, Mori S, Kanda Y et al (2004) Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after alogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 33:431–434
Wittel MB, Ibanez JP, Cisneros JM (2005) Quantitative pp65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solod organ transplant recipients. J Infect 51:188–194
Almyroudis NG, Jakubowski A, Jaffe D (2007) Predictors for persistent cytomegalovirus reactivation after T-cell depleted allogeneic hematopoietic stem cell transplantation. Transpl Infect Dis 9:286–294
Fica A, Cervera C, Perez N et al (2007) Immunohistochemically proven ctyomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests. Transpl Infect Dis 9:203–210
Vilaichone RK, Mahachai V, Eiam-ong S et al (2001) Necrotizing ileitis caused by cytomegalovirus in patient with systemic lupus erythematosus: case report. J Med Assoc Thai 84:S469–S473
Sakamoto O, Ando M, Yoshimatsu S et al (2002) Systemic lupus erythematosus complicated by cytomegalovirus-induced hemophagocytic syndrome and colitis. Intern Med 41:151–155
Bang S, Park YB, Kang BS et al (2004) CMV enteritis causing ileal perforation in underlying lupus enteritis. Clin Rheumaol 39:69–72
Disclosures
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fujita, M., Hatachi, S. & Yagita, M. Immunohistochemically proven cytomegalovirus gastrointestinal diseases in three patients with autoimmune diseases. Clin Rheumatol 27, 1057–1059 (2008). https://doi.org/10.1007/s10067-008-0846-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-008-0846-8